Amniotic Fluid Stem Cells with Low γ-Interferon Response Showed Behavioral Improvement in Parkinsonism Rat Model

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Chang, Yu Jen ^a   Ho, Tsung Yen ^b   Wu, Mei Ling ^a   Hwang, Shiaw Min ^a   Chiou, Tzyy Wen ^b   Tsai, Ming Song ^c,d,e  

^a FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^b NATIONAL DONG HWA UNIVERSITY   (Taiwan)

^c CATHAY GENERAL HOSPITAL   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; DOPAMINE TRANSPORTER; GAMMA INTERFERON; HLA ANTIGEN; HLA E ANTIGEN; HLA IA ANTIGEN; HLA II ANTIGEN; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ADULT; AMNION FLUID; AMNIOTIC FLUID STEM CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL SURFACE; CIITA GENE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; MESENCHYMAL STEM CELL; NONHUMAN; PARKINSONISM; PROTEIN EXPRESSION; RAT; REGULATOR GENE; RFX5 GENE; STEM CELL; STEM CELL TRANSPLANTATION; SUBSTANTIA NIGRA;

AMNIOTIC FLUID; ANIMALS; DNA PRIMERS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HLA ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; MESENCHYMAL STROMAL CELLS; MULTIPOTENT STEM CELLS; ORGANIC CHEMICALS; OXIDOPAMINE; PARKINSONIAN DISORDERS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; SUBSTANTIA NIGRA; TRANSCRIPTION FACTORS;

EID: 84884741566     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076118     Document Type: Article

References (45)

1. Trounson A, (2007) A fluid means of stem cell generation. Nat Biotechnol 25: 62-63. doi:10.1038/nbt0107-62. PubMed: 17211400.
2. Tsai MS, Hwang SM, Tsai YL, Cheng FC, Lee JL, et al. (2006) Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod 74: 545-551. doi:10.1095/biolreprod.105.046029. PubMed: 16306422.
3. De Coppi P, Bartsch G Jr., Siddiqui MM, Xu T, Santos CC, et al. (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25: 100-106. doi:10.1038/nbt1274. PubMed: 17206138.
4. Antonucci I, Stuppia L, Kaneko Y, Yu S, Tajiri N, et al. (2011) Amniotic fluid as a rich source of mesenchymal stromal cells for transplantation therapy. Cell Transplant 20: 789-795. doi:10.3727/096368910X539074. PubMed: 21054947.
5. Shaw SW, Bollini S, Nader KA, Gastadello A, Mehta V, et al. (2011) Autologous transplantation of amniotic fluid-derived mesenchymal stem cells into sheep fetuses. Cell Transplant 20: 1015-1031. doi:10.3727/096368910X543402. PubMed: 21092404.
6. Klemmt PA, Vafaizadeh V, Groner B, (2010) Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. Stem Cell Res Ther 1: 20. doi:10.1186/scrt20. PubMed: 20609228.
7. Pan HC, Cheng FC, Chen CJ, Lai SZ, Lee CW, et al. (2007) Post-injury regeneration in rat sciatic nerve facilitated by neurotrophic factors secreted by amniotic fluid mesenchymal stem cells. J Clin Neurosci 14: 1089-1098. doi:10.1016/j.jocn.2006.08.008. PubMed: 17954375.
8. Toulouse A, Sullivan AM, (2008) Progress in Parkinson's disease-where do we stand? Prog Neurobiol 85: 376-392. doi:10.1016/j.pneurobio.2008.05.003. PubMed: 18582530.
9. Wang Y, Chen S, Yang D, Le WD, (2007) Stem cell transplantation: a promising therapy for Parkinson's disease. J Neuroimmune Pharmacol 2: 243-250. doi:10.1007/s11481-007-9074-2. PubMed: 18040857.
10. Ahlskog JE, Muenter MD, (2001) Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 16: 448-458. doi:10.1002/mds.1090. PubMed: 11391738.
11. Piccini P, Brooks DJ, Björklund A, Gunn RN, Grasby PM, et al. (1999) Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 2: 1137-1140. doi:10.1038/16060. PubMed: 10570493.
12. Mendez I, Dagher A, Hong M, Gaudet P, Weerasinghe S, et al. (2002) Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases. J Neurosurg 96: 589-596. doi:10.3171/jns.2002.96.3.0589. PubMed: 11883846.
13. Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, et al. (2003) A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 54: 403-414. doi:10.1002/ana.10720. PubMed: 12953276.
14. Rogers J, Luber-Narod J, Styren SD, Civin WH, (1988) Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol Aging 9: 339-349. doi:10.1016/S0197-4580(88)80079-4. PubMed: 3263583.
15. Wyss-Coray T, Mucke L, (2002) Inflammation in neurodegenerative disease--a double-edged sword. Neuron 35: 419-432. doi:10.1016/S0896-6273(02)00794-8. PubMed: 12165466.
16. Mount MP, Lira A, Grimes D, Smith PD, Faucher S, et al. (2007) Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J Neurosci 27: 3328-3337. doi:10.1523/JNEUROSCI.5321-06.2007. PubMed: 17376993.
17. McGeer PL, Itagaki S, Tago H, McGeer EG, (1987) Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 79: 195-200. doi:10.1016/0304-3940(87)90696-3. PubMed: 3670729.
18. Jezierski A, Gruslin A, Tremblay R, Ly D, Smith C, et al. (2010) Probing stemness and neural commitment in human amniotic fluid cells. Stem. Cell Res 6: 199-214.
19. Tsai MS, Lee JL, Chang YJ, Hwang SM, (2004) Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 19: 1450-1456. doi:10.1093/humrep/deh279. PubMed: 15105397.
20. Chang YJ, Shih DT, Tseng CP, Hsieh TB, Lee DC, et al. (2006) Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells 24: 679-685. doi:10.1634/stemcells.2004-0308. PubMed: 16179428.
21. Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B, (1994) Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265: 106-109. doi:10.1126/science.8016643. PubMed: 8016643.
22. Fondaneche MC, Villard J, Wiszniewski W, Jouanguy E, Etzioni A, et al. (1998) Genetic and molecular definition of complementation group D in MHC class II deficiency. Hum Mol Genet 7: 879-885. doi:10.1093/hmg/7.5.879. PubMed: 9536093.
23. Romieu-Mourez R, François M, Boivin MN, Stagg J, Galipeau J, (2007) Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density. J Immunol 179: 1549-1558. PubMed: 17641021.
24. Peng H, Kolb R, Kennedy JE, Zheng J, (2007) Differential expression of CXCL12 and CXCR4 during human fetal neural progenitor cell differentiation. J Neuroimmune Pharmacol 2: 251-258. doi:10.1007/s11481-007-9081-3. PubMed: 18040858.
25. Wynn RF, Hart CA, Corradi-Perini C, O'Neill L, Evans CA, et al. (2004) A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104: 2643-2645. doi:10.1182/blood-2004-02-0526. PubMed: 15251986.
26. Chiavegato A, Bollini S, Pozzobon M, Callegari A, Gasparotto L, et al. (2007) Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat. J Mol Cell Cardiol 42: 746-759. doi:10.1016/j.yjmcc.2006.12.008. PubMed: 17300799.
27. Ghannam S, Bouffi C, Djouad F, Jorgensen C, Noël D, (2010) Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Ther 1: 2. doi:10.1186/scrt2. PubMed: 20504283.
28. Stagg J, Pommey S, Eliopoulos N, Galipeau J, (2006) Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell. Blood 107: 2570-2577. doi:10.1182/blood-2005-07-2793. PubMed: 16293599.
29. Chan JL, Tang KC, Patel AP, Bonilla LM, Pierobon N, et al. (2006) Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood 107: 4817-4824. doi:10.1182/blood-2006-01-0057. PubMed: 16493000.
30. Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB, (2010) Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLOS ONE 5: e9016. doi:10.1371/journal.pone.0009016. PubMed: 20126406.
31. Cho PS, Messina DJ, Hirsh EL, Chi N, Goldman SN, et al. (2008) Immunogenicity of umbilical cord tissue derived cells. Blood 111: 430-438. doi:10.1182/blood-2007-03-078774. PubMed: 17909081.
32. Drukker M, Katz G, Urbach A, Schuldiner M, Markel G, et al. (2002) Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A 99: 9864-9869. doi:10.1073/pnas.142298299. PubMed: 12114532.
33. Moretta L, Biassoni R, Bottino C, Mingari MC, Moretta A, (2001) Immunobiology of human NK cells. Transplant Proc 33: 60-61. doi:10.1016/S0041-1345(00)02790-1. PubMed: 11266706.
34. Lee N, Llano M, Carretero M, Ishitani A, Navarro F, et al. (1998) HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A 95: 5199-5204. doi:10.1073/pnas.95.9.5199. PubMed: 9560253.
35. Gobin SJ, van den Elsen PJ, (2000) Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G. Hum Immunol 61: 1102-1107.
36. Rousseau P, Masternak K, Krawczyk M, Reith W, Dausset J, et al. (2004) In vivo, RFX5 binds differently to the human leucocyte antigen-E,-F, and-G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner. Immunology 111: 53-65. doi:10.1111/j.1365-2567.2004.01783.x. PubMed: 14678199.
37. Selmani Z, Naji A, Gaiffe E, Obert L, Tiberghien P, et al. (2009) HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells. Transplantation 87: S62-S66. doi:10.1097/TP.0b013e3181a2a4b3. PubMed: 19424010.
38. Isacson O, Bjorklund LM, Schumacher JM, (2003) Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells. Ann Neurol 53 (Suppl 3):: S135-S148. doi:10.1002/ana.10482. PubMed: 12666105.
39. Yasuhara T, Matsukawa N, Hara K, Yu G, Xu L, et al. (2006) Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease. J Neurosci 26: 12497-12511. doi:10.1523/JNEUROSCI.3719-06.2006. PubMed: 17135412.
40. Kaviani A, Perry TE, Dzakovic A, Jennings RW, Ziegler MM, et al. (2001) The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg 36: 1662-1665. doi:10.1053/jpsu.2001.27945. PubMed: 11685697.
41. Fu YS, Cheng YC, Lin MY, Cheng H, Chu PM, et al. (2006) Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells 24: 115-124. doi:10.1634/stemcells.2005-0053. PubMed: 16099997.
42. Hellmann MA, Panet H, Barhum Y, Melamed E, Offen D, (2006) Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents. Neurosci Lett 395: 124-128. doi:10.1016/j.neulet.2005.10.097. PubMed: 16359791.
43. McLaughlin D, Tsirimonaki E, Vallianatos G, Sakellaridis N, Chatzistamatiou T, et al. (2006) Stable expression of a neuronal dopaminergic progenitor phenotype in cell lines derived from human amniotic fluid cells. J Neurosci Res 83: 1190-1200. doi:10.1002/jnr.20828. PubMed: 16555279.
44. Donaldson AE, Cai J, Yang M, Iacovitti L, (2009) Human amniotic fluid stem cells do not differentiate into dopamine neurons in vitro or after transplantation in vivo. Stem Cells Dev 18: 1003-1012. doi:10.1089/scd.2008.0300. PubMed: 19049321.
45. Neumann H, Schmidt H, Cavalié A, Jenne D, Wekerle H, (1997) Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha. J Exp Med 185: 305-316. doi:10.1084/jem.185.2.305. PubMed: 9016879.